aluates Reports

$ 0.0

Automative

Measles, Mumps, and Rubella Virus Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-11B12360

Global Measles Mumps and Rubella Virus Vaccine Industry Research Report Growth Trends and Competitive Analysis 2022 2028

BUY CHAPTERS

Measles, Mumps, and Rubella Virus Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-11B12360

Report

September 2024

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Merck

Minhai Bio

Shanghai Institute of Biological

Beijing Institute of Biological

Measles, Mumps, and Rubella Virus Vaccine - Market Size

The global market for Measles, Mumps, and Rubella Virus Vaccine was estimated to be worth US$ 388 million in 2023 and is forecast to a readjusted size of US$ 506.6 million by 2030 with a CAGR of 3.8% during the forecast period 2024-2030

Measles, Mumps, and Rubella Virus Vaccine - Market

The MMR vaccine is a vaccine against measles, mumps, and rubella (German measles).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Measles, Mumps, and Rubella Virus Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Measles, Mumps, and Rubella Virus Vaccine by region & country, by Type, and by Application.

The Measles, Mumps, and Rubella Virus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Measles, Mumps, and Rubella Virus Vaccine.

Market Segmentation

Scope of Measles, Mumps, and Rubella Virus Vaccine - Market Report

Report Metric	Details
Report Name	Measles, Mumps, and Rubella Virus Vaccine - Market
Forecasted market size in 2030	US$ 506.6 million
CAGR	3.8%
Forecasted years	2024 - 2030
Segment by Type:	Child Adult
Segment by Application	Public Private
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, Minhai Bio, Shanghai Institute of Biological, Beijing Institute of Biological
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Measles, Mumps, and Rubella Virus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Measles, Mumps, and Rubella Virus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Measles, Mumps, and Rubella Virus Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Measles, Mumps, and Rubella Virus Vaccine - Market size in 2030?

Ans: The Measles, Mumps, and Rubella Virus Vaccine - Market size in 2030 will be US$ 506.6 million.

Who are the main players in the Measles, Mumps, and Rubella Virus Vaccine - Market report?

Ans: The main players in the Measles, Mumps, and Rubella Virus Vaccine - Market are Merck, Minhai Bio, Shanghai Institute of Biological, Beijing Institute of Biological

What are the Application segmentation covered in the Measles, Mumps, and Rubella Virus Vaccine - Market report?

Ans: The Applications covered in the Measles, Mumps, and Rubella Virus Vaccine - Market report are Public, Private

What are the Type segmentation covered in the Measles, Mumps, and Rubella Virus Vaccine - Market report?

Ans: The Types covered in the Measles, Mumps, and Rubella Virus Vaccine - Market report are Child, Adult

Recommended Reports

Human Vaccines

Specialty Vaccines

Vaccine Technologies

1 Market Overview

1.1 Measles, Mumps, and Rubella Virus Vaccine Product Introduction

1.2 Global Measles, Mumps, and Rubella Virus Vaccine Market Size Forecast

1.2.1 Global Measles, Mumps, and Rubella Virus Vaccine Sales Value (2019-2030)

1.2.2 Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume (2019-2030)

1.2.3 Global Measles, Mumps, and Rubella Virus Vaccine Sales Price (2019-2030)

1.3 Measles, Mumps, and Rubella Virus Vaccine Market Trends & Drivers

1.3.1 Measles, Mumps, and Rubella Virus Vaccine Industry Trends

1.3.2 Measles, Mumps, and Rubella Virus Vaccine Market Drivers & Opportunity

1.3.3 Measles, Mumps, and Rubella Virus Vaccine Market Challenges

1.3.4 Measles, Mumps, and Rubella Virus Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Measles, Mumps, and Rubella Virus Vaccine Players Revenue Ranking (2023)

2.2 Global Measles, Mumps, and Rubella Virus Vaccine Revenue by Company (2019-2024)

2.3 Global Measles, Mumps, and Rubella Virus Vaccine Players Sales Volume Ranking (2023)

2.4 Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume by Company Players (2019-2024)

2.5 Global Measles, Mumps, and Rubella Virus Vaccine Average Price by Company (2019-2024)

2.6 Key Manufacturers Measles, Mumps, and Rubella Virus Vaccine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Measles, Mumps, and Rubella Virus Vaccine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Measles, Mumps, and Rubella Virus Vaccine

2.9 Measles, Mumps, and Rubella Virus Vaccine Market Competitive Analysis

2.9.1 Measles, Mumps, and Rubella Virus Vaccine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Measles, Mumps, and Rubella Virus Vaccine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Measles, Mumps, and Rubella Virus Vaccine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Child

3.1.2 Adult

3.2 Global Measles, Mumps, and Rubella Virus Vaccine Sales Value by Type

3.2.1 Global Measles, Mumps, and Rubella Virus Vaccine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Measles, Mumps, and Rubella Virus Vaccine Sales Value, by Type (2019-2030)

3.2.3 Global Measles, Mumps, and Rubella Virus Vaccine Sales Value, by Type (%) (2019-2030)

3.3 Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume by Type

3.3.1 Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume, by Type (2019-2030)

3.3.3 Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume, by Type (%) (2019-2030)

3.4 Global Measles, Mumps, and Rubella Virus Vaccine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Public

4.1.2 Private

4.2 Global Measles, Mumps, and Rubella Virus Vaccine Sales Value by Application

4.2.1 Global Measles, Mumps, and Rubella Virus Vaccine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Measles, Mumps, and Rubella Virus Vaccine Sales Value, by Application (2019-2030)

4.2.3 Global Measles, Mumps, and Rubella Virus Vaccine Sales Value, by Application (%) (2019-2030)

4.3 Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume by Application

4.3.1 Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume, by Application (2019-2030)

4.3.3 Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume, by Application (%) (2019-2030)

4.4 Global Measles, Mumps, and Rubella Virus Vaccine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Measles, Mumps, and Rubella Virus Vaccine Sales Value by Region

5.1.1 Global Measles, Mumps, and Rubella Virus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Measles, Mumps, and Rubella Virus Vaccine Sales Value by Region (2019-2024)

5.1.3 Global Measles, Mumps, and Rubella Virus Vaccine Sales Value by Region (2025-2030)

5.1.4 Global Measles, Mumps, and Rubella Virus Vaccine Sales Value by Region (%), (2019-2030)

5.2 Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume by Region

5.2.1 Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume by Region (2019-2024)

5.2.3 Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume by Region (2025-2030)

5.2.4 Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume by Region (%), (2019-2030)

5.3 Global Measles, Mumps, and Rubella Virus Vaccine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Measles, Mumps, and Rubella Virus Vaccine Sales Value, 2019-2030

5.4.2 North America Measles, Mumps, and Rubella Virus Vaccine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Measles, Mumps, and Rubella Virus Vaccine Sales Value, 2019-2030

5.5.2 Europe Measles, Mumps, and Rubella Virus Vaccine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Measles, Mumps, and Rubella Virus Vaccine Sales Value, 2019-2030

5.6.2 Asia Pacific Measles, Mumps, and Rubella Virus Vaccine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Measles, Mumps, and Rubella Virus Vaccine Sales Value, 2019-2030

5.7.2 South America Measles, Mumps, and Rubella Virus Vaccine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Sales Value, 2019-2030

5.8.2 Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Measles, Mumps, and Rubella Virus Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Measles, Mumps, and Rubella Virus Vaccine Sales Value

6.2.1 Key Countries/Regions Measles, Mumps, and Rubella Virus Vaccine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Measles, Mumps, and Rubella Virus Vaccine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Measles, Mumps, and Rubella Virus Vaccine Sales Value, 2019-2030

6.3.2 United States Measles, Mumps, and Rubella Virus Vaccine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Measles, Mumps, and Rubella Virus Vaccine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Measles, Mumps, and Rubella Virus Vaccine Sales Value, 2019-2030

6.4.2 Europe Measles, Mumps, and Rubella Virus Vaccine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Measles, Mumps, and Rubella Virus Vaccine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Measles, Mumps, and Rubella Virus Vaccine Sales Value, 2019-2030

6.5.2 China Measles, Mumps, and Rubella Virus Vaccine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Measles, Mumps, and Rubella Virus Vaccine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Measles, Mumps, and Rubella Virus Vaccine Sales Value, 2019-2030

6.6.2 Japan Measles, Mumps, and Rubella Virus Vaccine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Measles, Mumps, and Rubella Virus Vaccine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Measles, Mumps, and Rubella Virus Vaccine Sales Value, 2019-2030

6.7.2 South Korea Measles, Mumps, and Rubella Virus Vaccine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Measles, Mumps, and Rubella Virus Vaccine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Measles, Mumps, and Rubella Virus Vaccine Sales Value, 2019-2030

6.8.2 Southeast Asia Measles, Mumps, and Rubella Virus Vaccine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Measles, Mumps, and Rubella Virus Vaccine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Measles, Mumps, and Rubella Virus Vaccine Sales Value, 2019-2030

6.9.2 India Measles, Mumps, and Rubella Virus Vaccine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Measles, Mumps, and Rubella Virus Vaccine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Merck

7.1.1 Merck Company Information

7.1.2 Merck Introduction and Business Overview

7.1.3 Merck Measles, Mumps, and Rubella Virus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Merck Measles, Mumps, and Rubella Virus Vaccine Product Offerings

7.1.5 Merck Recent Development

7.2 Minhai Bio

7.2.1 Minhai Bio Company Information

7.2.2 Minhai Bio Introduction and Business Overview

7.2.3 Minhai Bio Measles, Mumps, and Rubella Virus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Minhai Bio Measles, Mumps, and Rubella Virus Vaccine Product Offerings

7.2.5 Minhai Bio Recent Development

7.3 Shanghai Institute of Biological

7.3.1 Shanghai Institute of Biological Company Information

7.3.2 Shanghai Institute of Biological Introduction and Business Overview

7.3.3 Shanghai Institute of Biological Measles, Mumps, and Rubella Virus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Shanghai Institute of Biological Measles, Mumps, and Rubella Virus Vaccine Product Offerings

7.3.5 Shanghai Institute of Biological Recent Development

7.4 Beijing Institute of Biological

7.4.1 Beijing Institute of Biological Company Information

7.4.2 Beijing Institute of Biological Introduction and Business Overview

7.4.3 Beijing Institute of Biological Measles, Mumps, and Rubella Virus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Beijing Institute of Biological Measles, Mumps, and Rubella Virus Vaccine Product Offerings

7.4.5 Beijing Institute of Biological Recent Development

8 Industry Chain Analysis

8.1 Measles, Mumps, and Rubella Virus Vaccine Industrial Chain

8.2 Measles, Mumps, and Rubella Virus Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Measles, Mumps, and Rubella Virus Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 Measles, Mumps, and Rubella Virus Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Merck

Minhai Bio

Shanghai Institute of Biological

Beijing Institute of Biological

List of Tables

Table 1. Measles, Mumps, and Rubella Virus Vaccine Market Trends

Table 2. Measles, Mumps, and Rubella Virus Vaccine Market Drivers & Opportunity

Table 3. Measles, Mumps, and Rubella Virus Vaccine Market Challenges

Table 4. Measles, Mumps, and Rubella Virus Vaccine Market Restraints

Table 5. Global Measles, Mumps, and Rubella Virus Vaccine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share by Company (2019-2024)

Table 7. Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Measles, Mumps, and Rubella Virus Vaccine Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Measles, Mumps, and Rubella Virus Vaccine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Measles, Mumps, and Rubella Virus Vaccine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Measles, Mumps, and Rubella Virus Vaccine

Table 13. Global Measles, Mumps, and Rubella Virus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Measles, Mumps, and Rubella Virus Vaccine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Measles, Mumps, and Rubella Virus Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Measles, Mumps, and Rubella Virus Vaccine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Measles, Mumps, and Rubella Virus Vaccine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Measles, Mumps, and Rubella Virus Vaccine Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Measles, Mumps, and Rubella Virus Vaccine Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Measles, Mumps, and Rubella Virus Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Measles, Mumps, and Rubella Virus Vaccine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Measles, Mumps, and Rubella Virus Vaccine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Measles, Mumps, and Rubella Virus Vaccine Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Measles, Mumps, and Rubella Virus Vaccine Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Measles, Mumps, and Rubella Virus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Measles, Mumps, and Rubella Virus Vaccine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Measles, Mumps, and Rubella Virus Vaccine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Measles, Mumps, and Rubella Virus Vaccine Sales Value by Region (2019-2024) & (%)

Table 44. Global Measles, Mumps, and Rubella Virus Vaccine Sales Value by Region (2025-2030) & (%)

Table 45. Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Measles, Mumps, and Rubella Virus Vaccine Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Measles, Mumps, and Rubella Virus Vaccine Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Measles, Mumps, and Rubella Virus Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Measles, Mumps, and Rubella Virus Vaccine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Measles, Mumps, and Rubella Virus Vaccine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Measles, Mumps, and Rubella Virus Vaccine Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Measles, Mumps, and Rubella Virus Vaccine Sales Volume, (2025-2030) & (K Units)

Table 57. Merck Company Information

Table 58. Merck Introduction and Business Overview

Table 59. Merck Measles, Mumps, and Rubella Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Merck Measles, Mumps, and Rubella Virus Vaccine Product Offerings

Table 61. Merck Recent Development

Table 62. Minhai Bio Company Information

Table 63. Minhai Bio Introduction and Business Overview

Table 64. Minhai Bio Measles, Mumps, and Rubella Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. Minhai Bio Measles, Mumps, and Rubella Virus Vaccine Product Offerings

Table 66. Minhai Bio Recent Development

Table 67. Shanghai Institute of Biological Company Information

Table 68. Shanghai Institute of Biological Introduction and Business Overview

Table 69. Shanghai Institute of Biological Measles, Mumps, and Rubella Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Shanghai Institute of Biological Measles, Mumps, and Rubella Virus Vaccine Product Offerings

Table 71. Shanghai Institute of Biological Recent Development

Table 72. Beijing Institute of Biological Company Information

Table 73. Beijing Institute of Biological Introduction and Business Overview

Table 74. Beijing Institute of Biological Measles, Mumps, and Rubella Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Beijing Institute of Biological Measles, Mumps, and Rubella Virus Vaccine Product Offerings

Table 76. Beijing Institute of Biological Recent Development

Table 77. Key Raw Materials Lists

Table 78. Raw Materials Key Suppliers Lists

Table 79. Measles, Mumps, and Rubella Virus Vaccine Downstream Customers

Table 80. Measles, Mumps, and Rubella Virus Vaccine Distributors List

Table 81. Research Programs/Design for This Report

Table 82. Key Data Information from Secondary Sources

Table 83. Key Data Information from Primary Sources

List of Figures

Figure 1. Measles, Mumps, and Rubella Virus Vaccine Product Picture

Figure 2. Global Measles, Mumps, and Rubella Virus Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Measles, Mumps, and Rubella Virus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume (2019-2030) & (K Units)

Figure 5. Global Measles, Mumps, and Rubella Virus Vaccine Sales Price (2019-2030) & (USD/Unit)

Figure 6. Measles, Mumps, and Rubella Virus Vaccine Report Years Considered

Figure 7. Global Measles, Mumps, and Rubella Virus Vaccine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Measles, Mumps, and Rubella Virus Vaccine Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Measles, Mumps, and Rubella Virus Vaccine Revenue in 2023

Figure 10. Measles, Mumps, and Rubella Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Child Picture

Figure 12. Adult Picture

Figure 13. Global Measles, Mumps, and Rubella Virus Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Measles, Mumps, and Rubella Virus Vaccine Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Measles, Mumps, and Rubella Virus Vaccine Price by Type (2019-2030) & (USD/Unit)

Figure 18. Product Picture of Public

Figure 19. Product Picture of Private

Figure 20. Global Measles, Mumps, and Rubella Virus Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Measles, Mumps, and Rubella Virus Vaccine Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 23. Global Measles, Mumps, and Rubella Virus Vaccine Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Measles, Mumps, and Rubella Virus Vaccine Price by Application (2019-2030) & (USD/Unit)

Figure 25. North America Measles, Mumps, and Rubella Virus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Measles, Mumps, and Rubella Virus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Measles, Mumps, and Rubella Virus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Measles, Mumps, and Rubella Virus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Measles, Mumps, and Rubella Virus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Measles, Mumps, and Rubella Virus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Measles, Mumps, and Rubella Virus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Measles, Mumps, and Rubella Virus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Measles, Mumps, and Rubella Virus Vaccine Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Measles, Mumps, and Rubella Virus Vaccine Sales Volume (%), (2019-2030)

Figure 37. United States Measles, Mumps, and Rubella Virus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Measles, Mumps, and Rubella Virus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Measles, Mumps, and Rubella Virus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Measles, Mumps, and Rubella Virus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Measles, Mumps, and Rubella Virus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Measles, Mumps, and Rubella Virus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 43. China Measles, Mumps, and Rubella Virus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Measles, Mumps, and Rubella Virus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 45. China Measles, Mumps, and Rubella Virus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Measles, Mumps, and Rubella Virus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Measles, Mumps, and Rubella Virus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Measles, Mumps, and Rubella Virus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Measles, Mumps, and Rubella Virus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Measles, Mumps, and Rubella Virus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Measles, Mumps, and Rubella Virus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Measles, Mumps, and Rubella Virus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Measles, Mumps, and Rubella Virus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Measles, Mumps, and Rubella Virus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 55. India Measles, Mumps, and Rubella Virus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Measles, Mumps, and Rubella Virus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 57. India Measles, Mumps, and Rubella Virus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 58. Measles, Mumps, and Rubella Virus Vaccine Industrial Chain

Figure 59. Measles, Mumps, and Rubella Virus Vaccine Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Mumps Vaccine Market Research Report 2025

Global Measles and Rubella Vaccine Market Research Report 2025

Global Measles Mumps Rubella and Varicella Combined Vaccine Market Research Report 2024

Global Measles and Rubella MR Vaccine Market Research Report 2025

Global Measles and Rubella Vaccines Market Research Report 2025

RSV Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Measles Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Mono Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Vaccines For Children Market Insights Forecast to 2030

Zoster Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Measle Vaccine Market Research Report 2025

Combination Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Immune Globulins Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Japanese Encephalitis Virus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Mono Hepatitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hepatitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Duck Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Combination Vaccines for Children Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-21N6899

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13M6952

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29X7355

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28B293

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Measles, Mumps, and Rubella Virus Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-11B12360

Measles, Mumps, and Rubella Virus Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Measles, Mumps, and Rubella Virus Vaccine - Market Size

Measles, Mumps, and Rubella Virus Vaccine - Market

Report Scope

Scope of Measles, Mumps, and Rubella Virus Vaccine - Market Report

Chapter Outline

FAQ for this report

What is the Measles, Mumps, and Rubella Virus Vaccine - Market size in 2030?

Who are the main players in the Measles, Mumps, and Rubella Virus Vaccine - Market report?

What are the Application segmentation covered in the Measles, Mumps, and Rubella Virus Vaccine - Market report?

What are the Type segmentation covered in the Measles, Mumps, and Rubella Virus Vaccine - Market report?

Recommended Reports

Human Vaccines

Specialty Vaccines

Vaccine Technologies

FEATURED COMPANIES

RELATED REPORTS